Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $783.82 | 35 | 84.9% |
| Education | $138.95 | 2 | 15.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $298.24 | 13 | $0 (2024) |
| Astellas Pharma US Inc | $157.89 | 5 | $0 (2024) |
| Allergan, Inc. | $113.87 | 3 | $0 (2020) |
| ABBVIE INC. | $112.18 | 5 | $0 (2024) |
| Insmed, Inc. | $56.99 | 2 | $0 (2024) |
| Cumberland Pharmaceuticals, Inc. | $44.12 | 2 | $0 (2023) |
| Melinta Therapeutics, LLC | $43.58 | 2 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $43.55 | 2 | $0 (2022) |
| Theravance Biopharma Inc. | $39.24 | 2 | $0 (2017) |
| ViiV Healthcare Company | $13.11 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $270.52 | 8 | Astellas Pharma US Inc ($113.94) |
| 2023 | $73.70 | 3 | Cumberland Pharmaceuticals, Inc. ($27.64) |
| 2022 | $89.54 | 5 | ABBVIE INC. ($38.15) |
| 2021 | $16.50 | 1 | Melinta Therapeutics, LLC ($16.50) |
| 2020 | $41.98 | 2 | Paratek Pharmaceuticals, Inc. ($21.75) |
| 2019 | $99.63 | 5 | Merck Sharp & Dohme Corporation ($39.27) |
| 2018 | $201.42 | 6 | Merck Sharp & Dohme Corporation ($107.78) |
| 2017 | $129.48 | 7 | Merck Sharp & Dohme Corporation ($74.31) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/18/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/23/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $53.69 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/17/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/08/2018 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $66.37 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/24/2017 | Merck Sharp & Dohme Corporation | CUBICIN RF (Drug), ZERBAXA, SIVEXTRO | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/04/2017 | Merck Sharp & Dohme Corporation | CUBICIN RF (Drug), ZERBAXA, SIVEXTRO | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/26/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Infectious Disease | ||||||
| 09/15/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Infectious Disease | ||||||
| 09/12/2017 | Merck Sharp & Dohme Corporation | CUBICIN RF (Drug), ZERBAXA, SIVEXTRO | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/05/2017 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Infectious Diseases | ||||||
| 08/08/2017 | Merck Sharp & Dohme Corporation | CUBICIN RF (Drug), ZERBAXA, SIVEXTRO | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 608 | 8,170 | $473,162 | $155,721 |
| 2022 | 11 | 647 | 4,928 | $354,382 | $111,266 |
| 2021 | 11 | 732 | 5,651 | $422,442 | $147,361 |
| 2020 | 8 | 605 | 996 | $180,742 | $66,408 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 34 | 34 | $13,532 | $5,024 | 37.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 30 | 81 | $17,010 | $4,506 | 26.5% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 11 | 11 | $4,488 | $2,420 | 53.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 22 | $4,268 | $2,133 | 50.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 20 | $2,640 | $1,352 | 51.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 13 | 13 | $2,938 | $1,038 | 35.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 22 | 24 | $2,176 | $729.12 | 33.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 284 | 590 | $83,190 | $33,351 | 40.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 128 | 130 | $42,428 | $13,291 | 31.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 81 | 120 | $23,760 | $9,863 | 41.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 24 | 68 | $14,280 | $3,640 | 25.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 39 | 39 | $8,840 | $2,985 | 33.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 11 | $4,378 | $1,767 | 40.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 13 | $1,716 | $761.50 | 44.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 25 | 25 | $2,150 | $750.24 | 34.9% |
About Dr. Majella Angelie Steinberg, D.O
Dr. Majella Angelie Steinberg, D.O is a Internal Medicine healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2009. The National Provider Identifier (NPI) number assigned to this provider is 1437385226.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Majella Angelie Steinberg, D.O has received a total of $922.77 in payments from pharmaceutical and medical device companies, with $270.52 received in 2024. These payments were reported across 37 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($783.82).
As a Medicare-enrolled provider, Steinberg has provided services to 2,592 Medicare beneficiaries, totaling 19,745 services with total Medicare billing of $480,757. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Pittsburgh, PA
- Active Since 06/08/2009
- Last Updated 01/26/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1437385226
Products in Payments
- DALVANCE (Drug) $186.10
- DIFICID (Drug) $174.04
- VIBATIV (Drug) $83.36
- CUBICIN RF (Drug) $74.31
- Arikayce (Drug) $56.99
- NUZYRA (Drug) $43.55
- TEFLARO (Drug) $39.95
- Cresemba (Drug) $30.87
- ZERBAXA (Drug) $29.26
- CRESEMBA (Drug) $28.02
- Rezzayo (Drug) $27.08
- NOXAFIL (Drug) $20.63
- Orbactiv (Drug) $16.50
- APRETUDE (Biological) $13.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pittsburgh
Christopher Gisler, Md, MD
Internal Medicine — Payments: $978,960
Dr. Joshua Silverstein, M.d, M.D
Internal Medicine — Payments: $472,100
Brian Henry, Md, MD
Internal Medicine — Payments: $207,815
Meilin Young, Md, MD
Internal Medicine — Payments: $155,901
Dr. Enrico Novelli, M.d, M.D
Internal Medicine — Payments: $114,138
Bassel Sayegh, M.d, M.D
Internal Medicine — Payments: $98,056